[PAR] YoY Quarter Result on 31-Dec-2022 [#Q2]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
30-Dec-2022
Financial Year
2023
Quarter
31-Dec-2022 [#Q2]
Profit Trend
QoQ- -159.82%
YoY- -18.09%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 17 0 5 45 0 826 28 -7.97%
PBT -6,255 -50,020 -32,643 -26,985 -20,730 -5,104 -4,400 6.03%
Tax -331 -1,061 -776 0 -0 826 0 -
NP -5,924 -48,958 -31,867 -26,985 -20,730 -5,104 -4,400 5.07%
Tax Rate - - - - - - - -
Total Cost 5,941 48,958 31,872 27,030 20,730 5,930 4,428 5.01%
Ratio Analysis
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -35,473.37 0.00 -676,581.74 -59,701.33 0.00 -617.95 -15,636.11 14.61%
Per Share
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -0.02 -0.16 -0.12 -0.11 -0.09 -0.03 -0.03 -6.52%
EPS Diluted -0.02 -0.16 -0.12 -0.11 -0.09 -0.03 -0.03 -6.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.